{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:30:53Z","timestamp":1789428653059,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"am","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.molcel.2025.06.004","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:02:06Z","timestamp":1750939326000},"page":"2673-2687.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Isoform-specific function of NSD3 in DNA replication stress confers resistance to PARP inhibitors in prostate cancer"],"prefix":"10.1016","volume":"85","author":[{"given":"Shouhai","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Indulkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake A.","family":"Kloeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaobin","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuntian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Dragojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongran","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1938-3091","authenticated-orcid":false,"given":"Zhenkun","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molcel.2025.06.004_bib1","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s11864-024-01215-2","article-title":"Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management","volume":"25","author":"Kulasegaran","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.molcel.2025.06.004_bib2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2025.06.004_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"Armenia","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molcel.2025.06.004_bib4","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.molcel.2025.06.004_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.clgc.2023.12.011","article-title":"PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing Evidence","volume":"22","author":"Ditonno","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.molcel.2025.06.004_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1470-2045(19)30684-9","article-title":"Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial","volume":"21","author":"Mateo","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molcel.2025.06.004_bib7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41571-021-00532-x","article-title":"Understanding and overcoming resistance to PARP inhibitors in cancer therapy","volume":"18","author":"Dias","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molcel.2025.06.004_bib8","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature06633","article-title":"Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers","volume":"451","author":"Sakai","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2025.06.004_bib9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nature06548","article-title":"Resistance to therapy caused by intragenic deletion in BRCA2","volume":"451","author":"Edwards","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2025.06.004_bib10","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2010.34.2980","article-title":"Secondary somatic mutations restoring BRCA1\/2 predict chemotherapy resistance in hereditary ovarian carcinomas","volume":"29","author":"Norquist","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molcel.2025.06.004_bib11","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1158\/2159-8290.CD-21-0007","article-title":"Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial","volume":"11","author":"Carreira","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molcel.2025.06.004_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-020-2188-x","article-title":"A reference map of the human binary protein interactome","volume":"580","author":"Luck","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2025.06.004_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-35880-y","article-title":"CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer","volume":"14","author":"Tsujino","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2025.06.004_bib14","article-title":"3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molcel.2025.06.004_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25346-4","article-title":"RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage","volume":"12","author":"Krais","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2025.06.004_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe7804","article-title":"SMARCAD1-mediated active replication fork stability maintains genome integrity","volume":"7","author":"Lo","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molcel.2025.06.004_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf7175","article-title":"Clinical PARP inhibitors allosterically induce PARP2 retention on DNA","volume":"9","author":"Langelier","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molcel.2025.06.004_bib18","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ncb3626","article-title":"EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation","volume":"19","author":"Rondinelli","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molcel.2025.06.004_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115440","article-title":"NSD3: Advances in cancer therapeutic potential and inhibitors research","volume":"256","author":"Xiu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molcel.2025.06.004_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2022.01.037","article-title":"Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitors","volume":"166","author":"Paulet","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.molcel.2025.06.004_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/0008-5472.CAN-20-0360","article-title":"NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression","volume":"81","author":"Jeong","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2025.06.004_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.molcel.2015.10.033","article-title":"NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler","volume":"60","author":"Shen","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2025.06.004_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature11935","article-title":"Replication stress links structural and numerical cancer chromosomal instability","volume":"494","author":"Burrell","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2025.06.004_bib24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41416-020-01114-x","article-title":"Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer","volume":"124","author":"Lozano","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.molcel.2025.06.004_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2025.06.004_bib26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1878-0261.12185","article-title":"Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells","volume":"12","author":"Feiersinger","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.molcel.2025.06.004_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.chembiol.2021.08.004","article-title":"A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells","volume":"29","author":"Xu","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molcel.2025.06.004_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114528","article-title":"Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferase","volume":"239","author":"Sun","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molcel.2025.06.004_bib29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1097-2765(03)00341-1","article-title":"BTB\/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases","volume":"12","author":"Geyer","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2025.06.004_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102879","article-title":"Diversity of structure and function in Cullin E3 ligases","volume":"88","author":"Lin","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.molcel.2025.06.004_bib31","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1074\/jbc.M701153200","article-title":"Substrate-mediated regulation of cullin neddylation","volume":"282","author":"Chew","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molcel.2025.06.004_bib32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.dnarep.2018.08.021","article-title":"Mechanisms of PARP inhibitor sensitivity and resistance","volume":"71","author":"D'Andrea","year":"2018","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.molcel.2025.06.004_bib33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm.2017.67","article-title":"The essential kinase ATR: ensuring faithful duplication of a challenging genome","volume":"18","author":"Saldivar","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molcel.2025.06.004_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molcel.2017.11.021","article-title":"Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic Regions","volume":"69","author":"Kim","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2025.06.004_bib35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tibs.2014.09.001","article-title":"Structure and function of the nucleosome-binding PWWP domain","volume":"39","author":"Qin","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molcel.2025.06.004_bib36","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1093\/nar\/gkab344","article-title":"The emerging determinants of replication fork stability","volume":"49","author":"Thakar","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molcel.2025.06.004_bib37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature18325","article-title":"Replication fork stability confers chemoresistance in BRCA-deficient cells","volume":"535","author":"Ray Chaudhuri","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2025.06.004_bib38","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1074\/jbc.M809158200","article-title":"Accumulation of Pax2 transactivation domain interaction protein (PTIP) at sites of DNA breaks via RNF8-dependent pathway is required for cell survival after DNA damage","volume":"284","author":"Gong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molcel.2025.06.004_bib39","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1088877","article-title":"BRCT repeats as phosphopeptide-binding modules involved in protein targeting","volume":"302","author":"Manke","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molcel.2025.06.004_bib40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.1088753","article-title":"The BRCT domain is a phospho-protein binding domain","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molcel.2025.06.004_bib41","doi-asserted-by":"crossref","first-page":"20395","DOI":"10.1074\/jbc.M701574200","article-title":"PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex","volume":"282","author":"Cho","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molcel.2025.06.004_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcac042","article-title":"Mechanisms of PARP1 inhibitor resistance and their implications for cancer treatment","volume":"4","author":"Jackson","year":"2022","journal-title":"NAR Cancer"},{"key":"10.1016\/j.molcel.2025.06.004_bib43","article-title":"A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.molcel.2025.06.004_bib44","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2025.06.004_bib45","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/cpt.2582","article-title":"Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate Cancer","volume":"111","author":"Qin","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molcel.2025.06.004_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.molcel.2023.01.003","article-title":"SUMOylation of HNRNPA2B1 modulates RPA dynamics during unperturbed replication and genotoxic stress responses","volume":"83","author":"Zhu","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2025.06.004_bib47","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-18-0474","article-title":"Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids","volume":"8","author":"Hill","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molcel.2025.06.004_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2025.06.004_bib49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molcel.2025.06.004_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-015-0033-4","article-title":"Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs","volume":"3","author":"Marquard","year":"2015","journal-title":"Biomark. Res."},{"key":"10.1016\/j.molcel.2025.06.004_bib51","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276525005040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276525005040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:51:16Z","timestamp":1762365076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097276525005040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1097276525005040"],"URL":"https:\/\/doi.org\/10.1016\/j.molcel.2025.06.004","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoform-specific function of NSD3 in DNA replication stress confers resistance to PARP inhibitors in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molcel.2025.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}